TRP_1170x120_3-8-19

Issue 05-13-2019

A new era dawns for chain drug retailing

A new era dawns for chain drug retailing

Like the mythical phoenix, the chain drug industry finds itself in the midst of a cycle of death and rebirth. The business model that has sustained the sector for decades is now under severe strain, with relentless reimbursement pressure in the pharmacy department, declining store traffic, and increased competition from traditional rivals and e-commerce retailers